{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T04:49:44Z","timestamp":1764305384987,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["13\/178\/01"],"award-info":[{"award-number":["13\/178\/01"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["13\/178\/01"],"award-info":[{"award-number":["13\/178\/01"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.tube.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T16:30:34Z","timestamp":1462033834000},"page":"81-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in\u00a0high-risk groups"],"prefix":"10.1016","volume":"99","author":[{"given":"Peter","family":"Auguste","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Tsertsvadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Court","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Pink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.tube.2016.04.007_bib1","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/j.1600-6143.2011.03625.x","article-title":"A\u00a0prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients","volume":"11","author":"Kim","year":"2011","journal-title":"Am J Transpl"},{"issue":"3","key":"10.1016\/j.tube.2016.04.007_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017984","article-title":"The tuberculin skin test versus QuantiFERON TB Gold in predicting tuberculosis disease in an adolescent cohort study in South Africa","volume":"6","author":"Mahomed","year":"2011","journal-title":"PLoS One"},{"year":"2011","series-title":"Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. CG117","author":"National Collaborating Centre for Chronic Conditions, Centre for Clinical Practice at NICE","key":"10.1016\/j.tube.2016.04.007_bib3"},{"issue":"3","key":"10.1016\/j.tube.2016.04.007_bib4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/thoraxjnl-2011-201542","article-title":"Community-based evaluation of immigrant tuberculosis screening using interferon gamma release assays and tuberculin skin testing: observational study and economic analysis","volume":"68","author":"Pareek","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.tube.2016.04.007_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices\u2013Modeling Studies","volume":"6","author":"Weinstein","year":"2003","journal-title":"Value Health"},{"year":"2014","series-title":"13\/178\/01: Accurate diagnosis of latent tuberculosis in children, in people who are immunocompromised or at risk from immunosuppression, and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation","author":"HTA","key":"10.1016\/j.tube.2016.04.007_bib6"},{"issue":"3","key":"10.1016\/j.tube.2016.04.007_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10198-013-0471-6","article-title":"Consolidated health economic evaluation reporting standards (CHEERS) statement","volume":"14","author":"Husereau","year":"2013","journal-title":"Eur J Health Econ"},{"issue":"36","key":"10.1016\/j.tube.2016.04.007_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta8360","article-title":"Review of guidelines for good practice in decision-analytic modelling in health technology assessment","volume":"8","author":"Philips","year":"2004","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.tube.2016.04.007_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03256394","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-alpha antagonist therapy","volume":"14","author":"Kowada","year":"2010","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"10.1016\/j.tube.2016.04.007_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03262207","article-title":"Cost effectiveness of interferon-gamma release assay for school-based tuberculosis screening","volume":"16","author":"Kowada","year":"2012","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"10.1016\/j.tube.2016.04.007_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ndt\/gfs479","article-title":"Cost effectiveness of the interferon- release assay for tuberculosis screening of hemodialysis patients","volume":"28","author":"Kowada","year":"2013","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"10.1016\/j.tube.2016.04.007_bib12","first-page":"32","article-title":"Cost effectiveness of interferon- release assay for TB screening of HIV positive pregnant women in low TB incidence countries","volume":"68","author":"Kowada","year":"2014","journal-title":"J\u00a0Infect"},{"issue":"1","key":"10.1016\/j.tube.2016.04.007_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.ajkd.2012.06.004","article-title":"Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children","volume":"61","author":"Laskin","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.tube.2016.04.007_bib14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201101-0181OC","article-title":"Priorities for screening and treatment of latent tuberculosis infection in the United States","volume":"184","author":"Linas","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.tube.2016.04.007_bib15","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1097\/MIB.0b013e31829f008f","article-title":"Cost-effectiveness of QuantiFERON testing before initiation of biological therapy in inflammatory bowel disease","volume":"19","author":"Swaminath","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.tube.2016.04.007_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/thoraxjnl-2011-200933","article-title":"Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting","volume":"68","author":"Mandalakas","year":"2013","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.tube.2016.04.007_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3020","article-title":"Handling uncertainty when performing economic evaluation of healthcare interventions","volume":"3","author":"Briggs","year":"1999","journal-title":"Health Technol Assess"},{"issue":"4","key":"10.1016\/j.tube.2016.04.007_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40258-015-0183-4","article-title":"A\u00a0systematic review of studies evaluating the cost utility of screening high-risk populations for latent tuberculosis infection","volume":"13","author":"Campbell","year":"2015","journal-title":"Appl Health Econ Health Policy"},{"issue":"8","key":"10.1016\/j.tube.2016.04.007_bib19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40273-015-0267-x","article-title":"Cost effectiveness of preventive treatment for tuberculosis in special high-risk populations","volume":"33","author":"Diel","year":"2015","journal-title":"Pharmacoeconomics"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215302845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215302845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:40:47Z","timestamp":1761468047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979215302845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":19,"alternative-id":["S1472979215302845"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2016.04.007","relation":{},"ISSN":["1472-9792"],"issn-type":[{"type":"print","value":"1472-9792"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in\u00a0high-risk groups","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2016.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}